SCHEMBL10676749

SCHEMBL10676749

Cc1ccc2c(c1)c(N(C)C)c(C(=O)N(C)c1ccccc1)c(=O)n2C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.60
▸ KMT2A Q03164 5/20 0.60
▸ PGR P06401 1/20 0.60
▸ SRC P12931 1/20 0.52
▸ PADI4 Q9UM07 1/20 0.42
▸ TP53 P04637 4/20 0.41
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ NLRP3 Q96P20 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MAPT P10636 3/20 0.38
▸ POLB P06746 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CASP3 P42574 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ SENP7 Q9BQF6 1/20 0.38
▸ SENP6 Q9GZR1 1/20 0.38
▸ HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10671888 0.87 MEN1 (0.76) MEN1KMT2APGRSRCPADI4
SCHEMBL10670006 0.87 KMT2A (0.74) MEN1KMT2APGRSRCTP53
SCHEMBL5165191 0.78 KMT2A (0.58) MEN1KMT2APGRSRCTP53
SCHEMBL10670471 0.78 MEN1 (0.76) MEN1KMT2APGRSRCTP53
SCHEMBL10671493 0.77 KMT2A (0.71) MEN1KMT2APGRSRCTP53
SCHEMBL10675968 0.76 MEN1 (0.77) MEN1KMT2APGRSRCTP53
Roquinimex SCHEMBL42132 0.75 KMT2A (1.00) MEN1KMT2APGRSRCTP53
Roquinimex SCHEMBL29359144 0.75 KMT2A (1.00) MEN1KMT2APGRSRCTP53
Roquinimex SCHEMBL8169579 0.75 KMT2A (1.00) MEN1KMT2APGRSRCTP53
SCHEMBL5164782 0.75 HDAC4 (0.58) MEN1KMT2APGRSRCALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4738971-A ENHANCED CELL-MEDIATED IMMUNITY; ANTIARTHRITIC AGENTS; NONTOXIC AKTIEBOLASET LEO (SE) 1988-04-19 — — US disclosed
US-4547511-A FOR ENHANCIN CELL-MEDIATED IMMUNITY AKTIEBOLAGET LEO (SE) 1985-10-15 — — US disclosed
EP-0059698-B1 HETEROCYCLIC CARBOXAMIDES, COMPOSITIONS CONTAINING SUCH COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND METHODS OF TREATMENT THEREWITH AB LEO (SE) 1985-09-25 — — EP disclosed
EP-0059698-A1 Heterocyclic carboxamides, compositions containing such compounds, processes for their preparation and methods of treatment therewith AB LEO (SE) 1982-09-08 — — EP disclosed
Send feedback